<DOC>
	<DOCNO>NCT00529438</DOCNO>
	<brief_summary>This study assess tolerability , safety , efficacy pharmacokinetics Bardoxolone methyl ( RTA 402 ) advance solid tumor lymphoid malignancy .</brief_summary>
	<brief_title>RTA 402 Patients With Advanced Solid Tumors Lymphoid Malignancies</brief_title>
	<detailed_description>Bardoxolone methyl ( RTA 402 ) synthetic triterpenoid demonstrate significant vivo single agent anti-cancer activity . This open-label phase I dose-escalation study Bardoxolone methyl ( RTA 402 ) administer orally first 21 day 28-day cycle .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Histopathological documentation solid tumor lymphoid malignancy . Advanced metastatic cancer either refractory relapse standardofcare curative survivalprolonging therapy , therapy exist . ECOG performance status less equal 2 Adequate liver renal function document follow laboratory test result within 14 day start therapy : total bilirubin ≤ 1.5 mg/dL ; AST ( SGOT ) ALT ( SGPT ) ≤ 2.5 ULN ≤ 5 ULN liver involve tumor ; serum creatinine ≤2.0 mg/dL OR creatinine clearance &gt; 60 mL/min . Adequate bone marrow function document follow laboratory test result within 14 day start therapy : platelet great 100,000/mm3 , absolute granulocyte count great 1,500/mm3 , hemoglobin great equal 8.0 g/dl . Completion prior chemotherapy , hormonal therapy , radiation therapy , biological therapy , investigational cancer therapy , least 4 week prior study entry must recover acute side effect ( CTC grade 1 less ) prior initiation RTA 402 . Patients receive mitomycin C nitrosoureas must 6 week last administration chemotherapy . Agree practice effective contraception entire study period . Life expectancy 3 month Able willing sign inform consent form . Willing able selfadminister orally document dos RTA 402 ingest . Active brain metastasis primary CNS malignancy . Pregnant breast feed Clinically significant illness include , limited : Uncontrolled diabetes ; Active uncontrolled infection ; Acute chronic liver disease ; Confirmed diagnosis HIV infection ; Uncontrolled hypertension , symptomatic congestive heart failure , unstable angina pectoris , myocardial infarction within past 6 month , uncontrolled cardiac arrhythmia . Psychiatric illness would limit compliance study requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>